G1
Alternative Names: Dermofural; G-1Latest Information Update: 02 Sep 2016
At a glance
- Originator Centro de Bioactivos Quimicos
- Developer CBQYM (CEASED)
- Class Antibacterials; Antifungals; Small molecules
- Mechanism of Action DNA inhibitors; Protein synthesis inhibitors; RNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Eye disorders; Mycoses
Most Recent Events
- 10 Apr 2007 No development reported - Phase-II for Eye disorders in Cuba (Topical)
- 10 Apr 2007 No development reported - Phase-III for Mycoses in Cuba (Topical)
- 12 Jun 2002 G1 is available for licensing [http://www.cbqym.com]